Abstract
Nonalcoholic fatty liver disease (NAFLD) is based on the concept of pathological morphology as well as clinical findings, and is broadly categorized into nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). The differential diagnosis between NAFL and NASH is important because NASH has the potential to progress to cirrhosis and hepatocellular carcinoma. NAFL is simple hepatic steatosis without hepatocellular injury, while NASH is characterized by macrovesicular steatosis, inflammation, and ballooning hepatocytes with a predominantly centrilobular (zone 3) distribution. Liver biopsy is a useful test for diagnosing NAFLD, but it is invasive. Therefore, various noninvasive methods including diagnostic imaging have been developed in recent years. To verify their usefulness, it is necessary to clarify in detail how the pathological findings are reflected in the image findings as imaging and histopathological findings are closely related. We describe the main histological features of NAFLD, i.e., steatosis, inflammation, ballooning hepatocytes, Mallory-Denk bodies, and fibrosis, as well as the evolutional process to liver cirrhosis.
Similar content being viewed by others
References
Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73–84.
Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of disease: practice Guideline by the American Association for the Study of Liver Diseases. Am College Gastroenterol Assoc Hepatol. 2018;67:328–57.
Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: mayo clinic experiences with a hitherto unnamed disease. Mayo ClinProc. 1980;55:434–8.
Matteoni CA, Younssi ZM, Gramlich T, et al. Non nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413–9.
Hashimoto E, Tokushige K, Ludwig J. Diagnosis and classification of non-alcoholic steatohepatitis: current concepts and remaining challenges. Hepatol Res. 2015;45:20–8.
Kuwashiro T, Takahashi H, Hyogo H, et al. Discordant pathological diagnosis of non-alcoholic fatty liver disease: a prospective multicenter study. JGH. 2020;4:497–502.
Gambino RG, Cassader M, Pagono G. Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease accuracy severity. Ann Med. 2011;43:617–49.
Cassinoto C, Boursier J, Ledinghen V, et al. (2016) Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan and ARFI with liver biopsy. Hepatology. 2016;63:1817–27.
Oeda S, Takahashi H, Imajo K, et al. Accuracy of liver stiffness measurement and controlled attenuation parameter using FibroScan M/XL probes to diagnose liver fibrosis and steatosis in patients with nonalcoholic fatty liver disease: a multicenter prospective study. J Gastoenterol. 2020;55:428–40.
Tada T, Iijima H, Kobayashi N, et al. Usefulness of attenuation imaging with an ultrasound saner for the evaluation of hepatic steatosis. Ultrasound Med Biol. 2019;45:2679–87.
Vuppalanchi R, Siddiqui MS, Van Natta ML, et al. Performance characteristics of vibration-controled transient elastography for evaluation of nonalcoholic fatty liver disease. Hepatology. 2018;67:134–44.
Noureddin M, Lam J, Peterson MR, et al. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology. 2013;58:1930–40.
Imajo K, Kessoku T, Honda Y, et al. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology. 2016;150:626–37.
Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467–74.
Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–21.
Brunt EM, Kleiner DE, Laura W, et al. Portal chronic inflammation in nonalcoholic fatty liver (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network. Hepatology. 2009;49:809–20.
Sakamoto M, Tsujikawa H, Effendi K, et al. Pathological findings of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease. Pathol Int. 2017;67:1–7.
Younossi ZM, Stepanova M, Rafiq N, et al. Pathologic criteria for nonalcoholic steatohepatitis; inter-protocol agreement and ability to predict liver-related mortality. Hepatopoly. 2011;53:1874–82.
Sanyal AJ, Brunt EM, Kleiner DE, et al. End points and clinical trial design for nonalcoholic steatohepatitis. Hepatology. 2011;54:344–53.
Zatloukal K, Denk H, Stumptner C, et al. From Mallory to Mallory-Denk inclusion bodies: what, how and why? Exp Cell Res. 2007;313:2033–49.
Diehl AM, Goodman Z, Ishak KG. Alcohol-like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroentelology. 1948;95:1056–62.
Angulo P, Kleiner DE, Dam-Larsen S, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver diseases. Gastroenterology. 2015;149:389–97.
Latry P, Bioulac-Sage P, Echinard E, et al. Perisinusoidal fibrosis and basement membrane-like material in the livers of diabetic patients. Hum Pathol. 1987;18:775–80.
Itoh S, Yougel T, Kawagoe K. Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis. Am J Gastroenterol. 1987;82:650–4.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest.
Ethical standards
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Kage, M., Aishima, S., Kusano, H. et al. Histopathological findings of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Med Ultrasonics 47, 549–554 (2020). https://doi.org/10.1007/s10396-020-01061-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10396-020-01061-3